OptMed Inc. Celebrates Important FDA Clearance
OptMed, Inc. is thrilled to announce a major achievement in its journey towards innovation in health care. The company has received the necessary clearance from the U.S. Food & Drug Administration (FDA) for its groundbreaking product, the 510(k) TearRepair™ Liquid Skin Protectant.
About TearRepair™ Liquid Skin Protectant
TearRepair™ Liquid Skin Protectant is a cutting-edge solution that utilizes a non-cytotoxic, methylidene malonate-based formula. This rapid-drying liquid acts as a barrier film to protect the skin effectively. Once applied, the liquid transforms into a transparent, flexible film within minutes, seamlessly adhering to the contours of the skin while remaining sterile. It provides a natural wear-off feature, ensuring user comfort and safety.
CEO's Vision and Future Goals
Ervin Braun, the CEO of OptMed, emphasized the significance of this clearance as a crucial milestone for the company. He stated, "OptMed will aggressively move forward to commercialize TearRepair™." Braun further noted how OptMed’s proprietary technology allows for the development of various products aimed at protecting the skin and treating acute, surgical, and chronic wounds, including lacerations and incisions.
Decade-Long Commitment to Innovation
For over 10 years, OptMed, Inc. has been dedicated to the development of revolutionary medical adhesives. The unique chemistry behind their product, methylidene malonate, sets it apart from existing market solutions and holds the potential to transform surgical procedures in the future.
Expanding Product Offerings
With FDA clearance now secured, OptMed is set to expand its portfolio to include both skin protectants and topical surgical adhesives. This achievement is a testament to the company’s commitment to pioneering advanced healthcare solutions. OptMed's next steps involve targeting the internal surgical adhesive market using their proprietary polymer technology.
Contact Information
For additional inquiries regarding this exciting development, please reach out to:
Ervin Braun
CEO - OptMed
M: (203) 273-7450
E-Mail: [email protected]
Frequently Asked Questions
What is TearRepair™ Liquid Skin Protectant?
TearRepair™ is a rapid-drying, liquid barrier film used to protect the skin, forming a flexible and transparent coat that is sterile.
Who is the CEO of OptMed, Inc.?
Ervin Braun serves as the CEO of OptMed, Inc., overseeing the company’s strategic direction and product development.
How does TearRepair™ differentiate itself from other products?
TearRepair™ features a unique methylidene malonate-based formula that is non-cytotoxic and designed for quick application and natural wear-off.
What future products can we expect from OptMed?
OptMed aims to explore additional product lines that address skin protection and various types of surgical adhesives using their proprietary technology.
How long has OptMed been developing TearRepair™?
OptMed has dedicated over a decade to developing their innovative medical adhesive technology, which has culminated in the introduction of TearRepair™.
